Delivery Order SPE2DB22D1002-SPE2DB25FLGB6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,376.52 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $1,125.76 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Refresh Plus 0.5% eye drops (30-unit package). This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The contract specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a $1,108.80 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Refresh Plus 0.5% eye drops (30 units). This firm fixed price, non-set-aside contract is scheduled for completion by August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the Defense Logistics Agency's Medical Supply Chain operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.94 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on September 12, 2025, with a completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger prime contract vehicle with DLA. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $1,548.00 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Refresh Plus 0.5% Eye Drops (30-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,275.48 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-unit dose) on May 15, 2025, with an ultimate completion date of May 16, 2025. The contract is priced on a firm fixed-price basis with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.57 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-unit quantity) on June 16, 2025, with a ceiling value of $2,492.13. This firm fixed-price delivery order, with an ultimate completion date of June 17, 2025, represents a competitive award with no set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.61 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops UD 50s on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,243.20 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on July 24, 2025, with completion targeted for July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLGB6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,112.13 to AmerisourceBergen Drug Corp on August 8, 2025, for Refresh Plus 0.5% eye drops (70 unit dose packages). This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is scheduled for completion by August 11, 2025, with performance at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor agreement extending through December 2026. The IDC serves as a global procurement vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs and other federal medical systems. The eye drops delivery represents a routine medical supply requirement within the company's broad portfolio of brand-name and generic medications, vaccines, and specialized healthcare commodities supporting Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/8/25 |